Clover Health Investments recently released its third-quarter 2024 financial results. The company reported a revenue of $331.0 million, which represents a 31% decline compared to the same period last year.

However, there was some positive news as well. Clover Health managed to narrow its net loss to $8.79 million, marking a significant 79% improvement year-over-year. The loss per share also improved from $0.086 in the third quarter of 2023 to $0.018 in the current quarter.

Despite these improvements, the company fell short of revenue estimates by 4.4%, while earnings per share exceeded analyst expectations by 54%. Looking ahead, Clover Health expects an average revenue growth of 4.1% per year over the next three years, which is lower than the projected 6.6% growth for the broader U.S. healthcare industry.

It's worth noting that the company's shares have declined by 11% over the past week, reflecting ongoing market challenges. Additionally, there are two warning signs in Clover Health's investment analysis, with one being particularly concerning.